Public list Pharma Startups (6570):
Company developing an 3-D biochip to enhance the capacity, efficiency, accuracy and automation of gene screening. The technology was originally developed at North Carolina State University.
Company (Alive / Active)
|Investor||Investor Type||Location||Participating Rounds|
|Tucson, Arizona, United States||IPO / Went public||HTG Molecular Diagnostics provides simple, cost effective solutions for accurate RNA testing. In 2013 the company commercialized its Edge instrument platform and a portfolio of mRNA assays that leverage HTG's proprietary nuclease protection chemistry. The capability of the Edge System has been expanded to fully automate sample and targeted library preparation for next-generation sequencing.||Login to see details|
|Lebanon, New Hampshire, United States||Acquired||GlycoFi, Inc. was founded in 2000 with the mission of dramatically improving the capacity and cost of producing human therapeutic proteins, while simultaneously enhancing their efficacy and safety as therapeutics. The company harnesses the inherent advantages of yeast and other fungal-based protein expression systems by engineering these systems to produce correctly glycosylated human therapeutic proteins, thus greatly increasing the efficiency, fidelity and scalability at which those proteins c...Show all||Login to see details|
|Title||Application Date||Patent Date||Status
(Patent / Application)